Closed
SectorHealthcare
9.62 13.18
24h
Min
8.3
Max
9.75
Income | 57M 6.1M |
---|---|
Sales | 68M 89M |
EPS | 0.12 |
Profit margin | 6.834 |
Employees | 353 |
EBITDA | 50M 12M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +274.04% upside |
Next Earnings | 31 Jul 2025 |
---|
Market Cap | 120M 519M |
---|---|
Previous open | -3.56 |
Previous close | 9.62 |
By Acuity
38%
62%
130 / 380 Healthcare
By Trading Central
Confidence
Bearish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 31.27 USD 274.04%
High 50 USD
Low 12 USD
Based on 11 Wall Street analysts offering 12 month price targets forREGENXBIO Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$